H1B Salary Data

Home › Employers › Advanced Oncology Group LLC

Advanced Oncology Group LLC: H-1B salaries and sponsorship

Advanced Oncology Group LLC filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $70,000.

Applications (LCAs)3
Certified3
Employer addressGlendora, CA
H-1B dependent employerNo
Median offered salary$70,000
Middle half of salaries$68,280–$80,000
10th–90th percentile$67,248–$86,000

Does Advanced Oncology Group LLC sponsor H-1B visas?

Advanced Oncology Group LLC filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on Apr 24, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Clinical Database Administrator1$70,000
Associate Medical Physicist1$90,000
Senior Health Education Specialist1$66,560

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20252$80,000
FY20261$66,560

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Senior Health Education Specialist$66,560
Level III
West Covina, CAApr 24, 2026Oct 1, 2026Certified
Clinical Database Administrator$70,000
Level I
West Covina, CAMay 14, 2025Oct 1, 2025Certified
Associate Medical Physicist$90,000
Level I
West Covina, CAMay 6, 2025Oct 1, 2025Certified

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).